MENU

NeuroMetrix (NURO) Ownership - Who owns NeuroMetrix?

Profile

Industry
Medical Specialties
Address
4B Gill Street
Phone
+1 781 890-9989
Employees
26
Web
https://www.neurometrix.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
8.07M
P/E Ratio
N/A
Total Cash
18M
Projected Growth
N/A
Total Debt
240.88K
Revenue
5.9M
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash/Share
9.06
Total Debt/Equity
N/A
Revenue/Share
5.66 USD as % of share price

Fundamentals

NURO
Capitalization
8.07M
P/E Ratio
N/A
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash
18M
Total Cash/Share
9.06
Total Debt
241K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.66%
Revenue
5.9M
ROE
N/A
Book Value
20.1M
P/B Ratio
0.40
Cash Flow
N/A
Earnings
-6.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
152
Current Ratio
16.81
Current Revenue Per Employee
50682.54
Dividends Per Share - Security
0.00
EBITDA
-7.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
64.35
Revenue To Assets
-28.33
Shares Held By Institutions
397K
Shares Outstanding - Current
1.99M
Total Liabilities
1.33M
Total Volume MTD
N/A
Value
1
Gain YTD
6.111
View a ticker or compare two or three
NURO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medical devices used for treatment of the neurological complications of diabetes

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
4B Gill Street
Phone
+1 781 890-9989
Employees
26
Web
https://www.neurometrix.com